CALCIUM ION DEPENDENT PHOSPHOKINASE C ISOFORMS IN ADAPTATION/INFLAMATION
CALCIUM ION DEPENDENT PHOSPHOKINASE C ISOFORMS IN ADAPTATION/INFLAMATION
批准号:
6340978
负责人:
ANIRBAN BANERJEE
金额:
$21.07万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-01 至 2001-03-31
中文摘要
PKC亚型在结构、CA++依赖性(CPKC)和受
脂类,但在所有被检查的组织中都存在。具体的组合
所表达的亚型是该细胞表型的特征。这
这表明这些异构体没有重叠的功能。虽然
蛋白激酶C抑制预适应诱导的功能性心脏保护
作为抑制剂,目前还不清楚这些异构体扮演着什么角色。几个PKC-
相关刺激,包括钙离子预适应,调节不同的模式
异构体易位到不同的肌细胞室。几个
一系列证据表明,每个受体都受到刺激,异构体
编码不同的保护机制。不同岗位的比较-
损伤结果表明,诱导预适应的刺激对
缺血后机械功能障碍不能自动预防
细胞死亡。此外,不同程度的功能保护对
渐进性严重缺血表明预适应刺激
它们的效力是不同的。值得注意的是,结果如功能性
保护似乎并不是简单地与
异构体参与或易位的程度,表明重要性
在正确的持续时间内,空间上精确的亚型易位。
这导致了一种假设,即‘PKC’介导的保护机制
或者炎症可能由不同的PKC亚型组合编码
特定的隔间。在本提案中,我们将在以前工作的基础上
心功能保护:1.评价一套心功能保护剂的疗效
抗心肌细胞凋亡和梗死的预适应刺激
发生在严重的缺血之后。绘制空间和时间移位图
对于这一组心脏应激、受体和
与PKC相关的直接刺激。3.确定中心的具体作用
心肌缺血后保护机制中的同工酶
功能障碍、脑梗塞和细胞凋亡。
包括常驻白细胞在内的一些心脏细胞表达cPKC亚型。
中性粒细胞和巨噬细胞在全身创伤后中的重要作用
炎症和当被适当的受体刺激时,已知
参与PKC的细胞毒作用。因此,我们将调查
PKC连接的受体是否也将独特的异构体转位到
这些炎性白细胞,由4.决定空间和时间
典型炎症刺激后异构体的移位和5。
评估cPKC亚型在介导细胞毒作用中的作用
适当刺激分离的人中性粒细胞和大鼠巨噬细胞。
英文摘要
PKC isoforms differ in structure, CA++ dependency (cPKC) and regulation by
lipids, but are present in all tissues examined. The specific combination
of isoforms expressed are characteristic of that cell phenotype. This
suggests that these isoforms do not have overlapping functions. Although
functional cardioprotection induced by preconditioning is inhibited by PKC
inhibitors, it is not clear what roles the isoforms play. Several PKC-
linked stimuli, including Ca++ preconditioning, mediate different patterns
of isoform translocation to different myocellular compartments. Several
lines of evidence suggest that each receptor stimulated, isoform-profile
encodes distinct mechanisms of protection. Comparison of different post-
injury outcomes indicates that stimuli conferring preconditioning against
post-ischemic mechanical dysfunction do not automatically protect against
cell-death. Further, different degrees of functional protection against
progressively severe ischemia indicates that preconditioning stimuli
differ in their potency. Significantly, outcomes such as functional
protection do not appear to be simply correlated with either the number of
isoform engaged or the extent of translocation, indicating the importance
of spatially precise isoform translocation, for the correct duration.
This leads to the hypothesis that 'PKC' mediated mechanisms of protection
or inflammation may be encoded by distinct combinations of PKC isoforms in
specific compartments. In this proposal we will build on previous work on
cardiac functional protection to 1. evaluate the efficacy of a set of
preconditioning stimuli against cardiac apoptosis and infarction that
occurs after severe ischemia. Map the spatial and temporal translocation
for each isoform engaged by this set of cardiac stress, receptor, and
direct PKC-linked stimuli. 3. Determine the specific role of the cPKC
isoforms in mediating mechanisms of cardioprotection against post-ischemic
dysfunction, infarction and apoptosis.
Several heart cells including resident leukocytes express cPKC isoforms.
Neutrophils and macrophages are important in systemic post-traumatic
inflammation and when stimulated by appropriate receptor, are known to
involves PKC in their cytotoxic functions. We will therefore investigate
whether PKC linked receptors also translocate unique isoform profiles in
these inflammatory leukocytes, by 4. determining the spatial and temporal
translocation of isoforms after prototypic inflammatory stimuli and 5.
assessing the role of the cPKC isoforms in mediating the cytotoxicity of
appropriately stimulated isolated human neutrophils and rat macrophages.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 3: Anti-Inflammatory Mechanisms of Inhaled Hypertonic Saline
-
批准号:8382283
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2012
-
负责人:ANIRBAN BANERJEE
-
依托单位:
Trauma Primes Cells
-
批准号:8069421
-
项目类别:
-
资助金额:$44.97万
-
财政年份:2010
-
负责人:ANIRBAN BANERJEE
-
依托单位:
CORE--CELL AND IMAGING
-
批准号:6973946
-
项目类别:
-
资助金额:$18.53万
-
财政年份:2005
-
负责人:ANIRBAN BANERJEE
-
依托单位:
POST-ENDOCYTOTIC INFLAMMATORY SIGNALING AFTER TRAUMA
-
批准号:6919600
-
项目类别:
-
资助金额:$16.22万
-
财政年份:2005
-
负责人:ANIRBAN BANERJEE
-
依托单位:
Administrative Core
-
批准号:6919601
-
项目类别:
-
资助金额:$14.85万
-
财政年份:2005
-
负责人:ANIRBAN BANERJEE
-
依托单位:
Core--Cytoskeletal Facility
-
批准号:6660107
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2002
-
负责人:ANIRBAN BANERJEE
-
依托单位:
Core--Cytoskeletal Facility
-
批准号:6585990
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2002
-
负责人:ANIRBAN BANERJEE
-
依托单位:
CALCIUM ION DEPENDENT PHOSPHOKINASE C ISOFORMS IN ADAPTATION/INFLAMATION
-
批准号:6296720
-
项目类别:
-
资助金额:$21.07万
-
财政年份:1999
-
负责人:ANIRBAN BANERJEE
-
依托单位:
CALCIUM ION DEPENDENT PHOSPHOKINASE C ISOFORMS IN ADAPTATION/INFLAMATION
-
批准号:6107678
-
项目类别:
-
资助金额:$21.07万
-
财政年份:1999
-
负责人:ANIRBAN BANERJEE
-
依托单位:
TRAUMA PRIMES CELLS
-
批准号:6919553
-
项目类别:
-
资助金额:$43.28万
-
财政年份:1998
-
负责人:ANIRBAN BANERJEE
-
依托单位:
CALCIUM ION DEPENDENT PHOSPHOKINASE C ISOFORMS IN ADAPTATION/INFLAMATION
-
批准号:6505069
-
项目类别:
-
资助金额:$18.67万
-
财政年份:1998
-
负责人:ANIRBAN BANERJEE
-
依托单位:
CALCIUM ION DEPENDENT PHOSPHOKINASE C ISOFORMS IN ADAPTATION/INFLAMATION
-
批准号:6271803
-
项目类别:
-
资助金额:$16.82万
-
财政年份:1998
-
负责人:ANIRBAN BANERJEE
-
依托单位:
Overall Application: Trauma Primes Cells
-
批准号:8499325
-
项目类别:
-
资助金额:$205.74万
-
财政年份:1997
-
负责人:ANIRBAN BANERJEE
-
依托单位:
Overall Application: Trauma Primes Cells
-
批准号:8337305
-
项目类别:
-
资助金额:$213.27万
-
财政年份:1997
-
负责人:ANIRBAN BANERJEE
-
依托单位:
Trauma Primes Cells
-
批准号:7667363
-
项目类别:
-
资助金额:$194.49万
-
财政年份:1997
-
负责人:ANIRBAN BANERJEE
-
依托单位:
ENDOGENOUS PRECONDITIONING PROTECTS AGAINST SHOCK
-
批准号:6240578
-
项目类别:
-
资助金额:$15.38万
-
财政年份:1997
-
负责人:ANIRBAN BANERJEE
-
依托单位:
Trauma Primes Cells
-
批准号:7214641
-
项目类别:
-
资助金额:$186.56万
-
财政年份:1997
-
负责人:ANIRBAN BANERJEE
-
依托单位:
Overall Application: Trauma Primes Cells
-
批准号:8903987
-
项目类别:
-
资助金额:$191.78万
-
财政年份:1997
-
负责人:ANIRBAN BANERJEE
-
依托单位:
Overall Application: Trauma Primes Cells
-
批准号:8678938
-
项目类别:
-
资助金额:$191.82万
-
财政年份:1997
-
负责人:ANIRBAN BANERJEE
-
依托单位:
Trauma Reprograms Cells
-
批准号:9209196
-
项目类别:
-
资助金额:$155.12万
-
财政年份:1997
-
负责人:ANIRBAN BANERJEE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: